Compare AbCellera Biologics Inc (ABCL) vs Amylx Pharmaceuticals Inc (AMLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Amylx Pharmaceuticals Inc — how do they compare? AbCellera Biologics Inc trades at $9.13 (market cap $2.99B), while Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.64B). The key difference: AbCellera Biologics Inc and Amylx Pharmaceuticals Inc are close in size by market cap. Which is the better fit depends on your goals.
| ABCL | AMLX | |
|---|---|---|
Market Cap | $2.99B | $2.64B |
Sector | Health | Health |
52-Week High | $9.76 | $24.19 |
52-Week Low | $2.78 | $7.82 |
Enterprise Value | $2.58B | $2.39B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →
